In colorectal cancer (CRC), NDRG1 downregulation was found to be essential for driving Claudin-2 (CLDN2)-mediated cell proliferation and migration/invasion in vitro and in vivo. The gene discussed is CLDN2; the disease is colorectal carcinoma.